Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
SKYSCRAPER-05: A Phase 2 Study of Perioperative Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Patients With Previously Untreated, Locally Advanced, Resectable, Stage II‒IIIB NSCLC.
Percutaneous Trigeminal Ganglion Stimulation as a Treatment Modality for Anesthesia Dolorosa: A Case Report.
Pathophysiology and Emerging Therapies in Chronic Inflammation Demyelinating Polyneuropathy.
Ocrelizumab-related organizing pneumonia in multiple sclerosis: insights from a case series and literature review.
Opsoclonus-Myoclonus-Ataxia Revealing Underlying Neuromyelitis Optica Spectrum Disorder.
Strongyloides hyperinfection complicated by invasive aspergillosis and osmotic demyelination syndrome.
The Role of Self-Compassion on Self-Care With the Mediating Role of Illness Perception in Patients With Multiple Sclerosis Referred to Sina Hospital: Based on the Leventhal Model.
Selegiline induces neuroprotection via PGC-1α/Nrf2 gene upregulation in H2O2 -treated hippocampal-derived neural stem/progenitor cells.
Exploring Healthcare Continuity in Pediatric-Onset Multiple Sclerosis in the United States.
Wernicke's Encephalopathy in a Young Non-alcoholic Woman Secondary to Prolonged Reduced Oral Intake: A Case Report.
Marked Discordance Between Visual Field Loss and Optic Disc Cupping Revealing MOG Antibody-Associated Optic Neuritis in a Patient With Angle-Closure Glaucoma.
The Roles of Transcription Factor Ets-1 in Neurological Disorders.
Minocycline ameliorates CNS autoimmunity through restraint of CD4CD11bc cells.
EBV reactivation priming of the peripheral immune system in multiple sclerosis relapse.
The effects of abused drugs on ferroptosis pathways: potential therapeutic targets for substance use disorders.
Effect of intrathecal injection of mesenchymal stem cell-neural progenitors on cerebrospinal fluid biomarkers in progressive multiple sclerosis.
Oral supplementation of 6'-sialyllactose in early-life enhances cognitive function in mice via modulating gut microbiota and promoting brain myelination.
A Study on the Correlation Between Clinical Features of Chronic Relapsing Inflammatory Optic Neuropathy and Myelin Oligodendrocyte Glycoprotein Antibodies.
The cost of imbalance: how balance problems drive energy cost of walking in persons with multiple sclerosis.
Machine learning identifies microbiome and clinical predictors of sustained weight loss following prolonged fasting.
Developmental changes in hypoglossal canal morphometry and its anatomical relationships: a CT study in 180 pediatric patients.
Diagnostic value of the kappa free light chain index in multiple sclerosis under the 2024 CSF positivity criterion: a multicentre study in oligoclonal band-negative patients.
Autotaxin as a potential biomarker in hepatic encephalopathy: Insights from a mouse model and cirrhotic patients.
Multi-omics Insights into Oxidative Stress-related Genes and Neurodegenerative Diseases: From Epigenetic Regulation to Pathogenic Pathways.
Digital signatures of fatigue and wearing-off symptoms in patients with multiple sclerosis under natalizumab.
Pages
« first
‹ previous
…
960
961
962
963
964
965
966
967
968
next ›
last »